GNPXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Genprex, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$2.06−0.05 (-2.37%)
Close on Oct 19, 2026
- Market cap
- $974.71K
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0.1%
0M of 1M shares
Institutional holders
2
2 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 2 sales
Net sold $22
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of GNPX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Cheviot Value Management, LLC | 1,000 | 0.12% | $519 | New | 0.00% |
| Harbour Investments, Inc. | 108 | 0.01% | $56 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2 | 0M | 0.1% | 2 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Ryan M. Confer | President, CEO and CFO, Director | 36,331 | 4.43% | Feb 27, 2026 |
| Mark Stanley Berger | Chief Medical Officer | 21,692 | 2.65% | Feb 27, 2026 |
| Brent M. Longnecker | Director | 9,157 | 1.12% | Apr 15, 2026 |
| William R. Wilson Jr. | Director | 9,157 | 1.12% | Dec 23, 2025 |
| Toscano Jose Antonio Moreno | Director | 9,157 | 1.12% | Dec 23, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Brent M. Longnecker Director | Apr 14, 2026 | Sale | −10 | $1.23 | $12 | 0 |
| Brent M. Longnecker Director | Apr 14, 2026 | Sale | −8 | $1.23 | $10 | 9,157 |
| Mark Stanley Berger Chief Medical Officer | Feb 27, 2026 | Tax withholding | −7,168 | $2.00 | $14.34K | 21,692 |
| Ryan M. Confer President, CEO and CFO, Director | Feb 27, 2026 | Tax withholding | −9,330 | $2.00 | $18.66K | 36,331 |
| Toscano Jose Antonio Moreno Director | Dec 22, 2025 | Award | +9,000 | – | – | 9,157 |
| Brent M. Longnecker Director | Dec 22, 2025 | Award | +9,000 | – | – | 9,165 |
| Ryan M. Confer President, CEO and CFO, Director | Dec 22, 2025 | Award | +45,000 | – | – | 45,661 |
| Mark Stanley Berger Chief Medical Officer | Dec 22, 2025 | Award | +28,500 | – | – | 28,860 |
| William R. Wilson Jr. Director | Dec 22, 2025 | Award | +9,000 | – | – | 9,157 |
| Ryan M. Confer President, CEO and CFO, Director | Jun 30, 2025 | Tax withholding | −5,775 | $0.23 | $1.33K | 32,968 |
| Mark Stanley Berger Chief Medical Officer | Jun 30, 2025 | Tax withholding | −4,500 | $0.23 | $1.04K | 17,971 |
| Mark Stanley Berger Chief Medical Officer | Feb 18, 2025 | Tax withholding | −585 | $0.41 | $240 | 22,471 |
| Ryan M. Confer President, CEO and CFO, Director | Feb 18, 2025 | Tax withholding | −395 | $0.41 | $162 | 38,743 |
| Ryan M. Confer President, CEO and CFO, Director | Dec 5, 2024 | Award | +29,375 | – | – | 39,138 |
| William R. Wilson Jr. Director | Dec 5, 2024 | Award | +4,750 | – | – | 7,845 |
| Brent M. Longnecker Director | Dec 5, 2024 | Award | +4,750 | – | – | 8,220 |
| Mark Stanley Berger Chief Medical Officer | Dec 5, 2024 | Award | +18,250 | – | – | 23,056 |
| Toscano Jose Antonio Moreno Director | Dec 5, 2024 | Award | +4,750 | – | – | 7,845 |
| Ryan M. Confer Chief Financial Officer | Feb 18, 2024 | Tax withholding | −1,126 | $4.40 | $4.95K | 9,763 |
| Mark Stanley Berger Chief Medical Officer | Feb 18, 2024 | Tax withholding | −1,319 | $4.40 | $5.80K | 4,806 |
| John Rodney Varner Chairman, President and CEO, Director | Feb 18, 2024 | Tax withholding | −2,642 | $4.40 | $11.62K | 26,352 |
| William R. Wilson Jr. Director | Jun 27, 2023 | Award | +123,795 | – | – | 123,795 |
| Toscano Jose Antonio Moreno Director | Jun 27, 2023 | Award | +123,795 | – | – | 123,795 |
| Brent M. Longnecker Director | Jun 27, 2023 | Award | +123,795 | – | – | 138,795 |
| John Rodney Varner Chairman, President and CEO, Director | Apr 21, 2023 | Buy | +19,000 | $1.06 | $20.14K | 20,800 |
| Catherine M. Vaczy EVP GC Chief Strategy Officer | Apr 21, 2023 | Buy | +20,000 | $1.07 | $21.40K | 265,000 |
| Mark Stanley Berger Chief Medical Officer | Feb 18, 2023 | Award | +245,000 | – | – | 245,000 |
| Hermant Kumar Chief Mfgr & Tech Officer | Feb 18, 2023 | Award | +200,000 | – | – | 200,000 |
| John Rodney Varner President & CEO, Director | Feb 18, 2023 | Award | +625,000 | – | – | 1,159,735 |
| Ryan M. Confer Chief Financial Officer | Feb 18, 2023 | Award | +245,000 | – | – | 435,499 |
| Catherine M. Vaczy EVP GC Chief Strategy Officer | Feb 18, 2023 | Award | +245,000 | – | – | 245,000 |
| Ryan M. Confer Chief Financial Officer | Jul 28, 2022 | Option exercise | +116,973 | $0.02 | $2.34K | 190,499 |
| John Rodney Varner President & CEO, Director | Jun 14, 2021 | Gift | −1,614,152 | – | – | 0 |
| Brent M. Longnecker Director | Apr 5, 2021 | Buy | +15,000 | $4.15 | $62.25K | 15,000 |
| John Rodney Varner Chief Executive Officer, Director, 10% owner | Sep 5, 2019 | Buy | +1,800 | $0.89 | $1.60K | 1,800 |
| Jack A. Roth 10% owner | Dec 5, 2018 | Other | −250,000 | – | – | 814,853 |
| Jack A. Roth 10% owner | Dec 5, 2018 | Other | −0 | – | – | 646,960 |
| Viet-An Hoan Ly 10% owner | Sep 27, 2018 | Other | −583,008 | – | – | 0 |
| Viet-An Hoan Ly 10% owner | Sep 27, 2018 | Other | −102,000 | – | – | 0 |
| Viet-An Hoan Ly 10% owner | Sep 27, 2018 | Other | −475,974 | – | – | 36,067 |
| Julien L. Pham President & COO | Jul 30, 2018 | Buy | +500 | $3.40 | $1.70K | 500 |
| Jack A. Roth 10% owner | Mar 29, 2018 | Buy | +40,000 | $5.00 | $200.00K | 1,338,999 |
| John Rodney Varner Chief Executive Officer, Director, 10% owner | Mar 29, 2018 | Buy | +10,000 | $5.00 | $50.00K | 544,735 |
| Christy M. Nance 10% owner | Mar 29, 2018 | Buy | +50,000 | $5.00 | $250.00K | 50,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.